Clinical end point acceptance limit [Study As­sess­ment]

posted by PKS – India, 2019-04-05 08:45 (604 d 15:15 ago) – Posting: # 20125
Views: 2,481

Should I conclude bio-equivalence with the values of [-0.2025, 0.076] in clinical end point study. Can I assume it as within the interval of (-0.20, 0.20)


Edit: Category changed; see also this post #1. Please follow the Forum’s Policy[Helmut]

Complete thread:

Activity
 Admin contact
21,220 posts in 4,427 threads, 1,481 registered users;
online 13 (0 registered, 13 guests [including 9 identified bots]).
Forum time: Sunday 23:01 CET (Europe/Vienna)

Half the harm that is done in this world
Is due to people who want to feel important.    T. S. Eliot

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5